Market Highlights
Anti-fungal agents are used in the treatment of infections caused by fungus. According to global action fund for fungal infection, globally, over 300 million people of all ages suffer from a serious fungal infection every year. The market drivers include rising prevalence of fungal infections, rising awareness, rise of immunity deficient population such as geriatrics, rise in exposure to infectious agents due to environmental factors such as pollution especially by particulates and agriculture residues and climatic conditions such as humidity and temperature, occupational hazards such as Jock itch, crowding etc. Growth of fungal infection due to off label use of broad spectrum antibiotics is a prime factor for the growing market for anti-fungal agents.
get a free sample @ https://www.marketresearchfuture.com/sample_request/2582
Anti-Fungal Agents Market of Middle East and Africa Market Highlight:
The Anti-Fungal Market drivers incorporate rising commonness of fungal contaminations, rising mindfulness, ascent of resistance inadequate populace, for example, geriatrics, ascend in presentation to irresistible operators because of ecological factors, for example, contamination particularly by particulates and horticulture deposits and climatic conditions, for example, stickiness and temperature, word related perils, for example, Jock itch, crowding and so on.
Taking all factors into consideration, we expect the Middle East and Africa Antifungal Drugs Market to reach around $2.85 billion by 2022 from $2.32 billion in 2015, by the end of the forecast period at a CAGR of 3.5%.
The Middle East and Africa anti-fungal agents market is led by Azoles followed by Echinocandins. The Azole class is represented in the market by agents such as Noxafil, Vfend, and Diflucan.
The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and genericitization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents.
Market Segments:
Drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others.
Route of administration; market is segmented into oral, local and others.
On the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others.
Browse Report @ https://www.marketresearchfuture.com/reports/mea-anti-fungal-agents-market-2582 .
Regional Analysis of Middle East and Africa Anti-fungal agents Market:
Overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
UAE is the largest market for anti-fungal agents in entire Middle East and Africa anti-fungal agents Market closely followed by Egypt. The rest of Africa market is however the fastest growing with a huge unmet medical needs and peculiar climatic conditions that support growth of fungal infections.
related reports
related reports
Ayurvedic Products Market Research Report- Forecast to 2027
Ophthalmoplegia Market Research Report- Global Forecast Till 2027
Lichen Sclerosus Treatment Market Research Report - Global forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
